Tilray | TRLY - Crediti Commerciali

Prezzo Delle Azioni
8.26
Cambio Giornaliero
-0.70 -7.81%
Mensile
-1.08%
Annuale
1,114.71%
Q2 Previsione
9.04




Crediti Commerciali Cambiamento Data
Acasti Pharma USD 20K 0 2025-09
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
Aurora Cannabis CAD 48.26M 1.53M 2025-12
Avita Medical AUD 9.11M 2.26M 2025-12
Canopy Growth CAD 140.42M 113.56M 2025-12
Cronos Group USD 78.04M 17.64M 2025-12
Dianthus Therapeutics USD 52K 4.95M 2025-12
Divis Laboratories Ltd INR 26.28B 1.16B 2025-09
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
IQVIA Holdings USD 3.43B 113M 2025-12
Knight Therapeutics CAD 183M 7.46M 2025-12
Moderna USD 184M 862M 2025-12
Organigram Holdings CAD 49.94M 14.92M 2025-12
Organon & Co USD 1.48B 0 2025-09
Revvity USD 744.67M 64.41M 2025-12
Tectonic Therapeutic USD 0 270K 2023-12
Tilray USD 109.07M 2M 2025-09
Viatris USD 3.03B 340.3M 2025-12
Xeris Pharmaceuticals USD 51.05M 2.7M 2025-12
Zealand Pharma A/S 340M 94.1M 2025-12